Angiogenesis Inhibitors: all 4,430 studies that test it

Page 14 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).TerminatedNCT01021423Phase 3Results posted
• Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)CompletedNCT01020747Phase 1Results posted
• Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval ChangesCompletedNCT01017731Phase 2Results posted
• Radiosurgery and Avastin for Recurrent Malignant GliomasCompletedNCT01017250Not applicableResults posted
• Azacitidine and Lenalidomide for Acute Myeloid LeukemiaCompletedNCT01016600Phase 1/2Results posted
• Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01013285Phase 2Results posted
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT01012973Phase 3Results posted
• Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine LeiomyosarcomaTerminatedNCT01012297Phase 3Results posted
• Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of AgeCompletedNCT01011894Phase 2Results posted
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerCompletedNCT01010126Phase 2Results posted
• A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile DuctsCompletedNCT01007552Phase 2Results posted
• Study of IMC-1121B in Patients With Advanced Solid TumorsCompletedNCT01005355Phase 1Results posted
• Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial CancerCompletedNCT01005329Phase 2Results posted
• Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for GlioblastomaCompletedNCT01004874Phase 2Results posted
• A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell CancerCompletedNCT01004250Phase 2Results posted
• Carboplatin and Bevacizumab for Progressive Breast Cancer Brain MetastasesCompletedNCT01004172Phase 2Results posted
• Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic LeukemiaTerminatedNCT01003769Phase 1/2Results posted
• Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein OcclusionsCompletedNCT01003106Phase 1/2Results posted
• Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01002755Phase 2Results posted
• A Study of Cisplatin + Pemetrexed + Avastin as First-Line TherapyTerminatedNCT00998166Phase 2Results posted
• Efficacy and Safety of Lenalidomide for Treatment of Autistic Spectrum DisordersCompletedNCT00996931Phase 2Results posted
• Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate CancerTerminatedNCT00996502Phase 1/2Results posted
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)CompletedNCT00996437Phase 2/3Results posted
• A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginCompletedNCT00993044Phase 1Results posted
• Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT00989989Phase 3Results posted
• Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerCompletedNCT00988208Phase 3Results posted
• A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell CarcinomaTerminatedNCT00982657Phase 2Results posted
• Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian CancerCompletedNCT00979992Phase 2Results posted
• Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma MultiformeCompletedNCT00979017Phase 2Results posted
• Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerActive, not recruitingNCT00977574Phase 2Results posted
• AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian CancerCompletedNCT00976911Phase 3Results posted
• Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung CancerCompletedNCT00976456Phase 3Results posted
• Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell CarcinomaTerminatedNCT00975806Phase 1/2Results posted
• Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLLCompletedNCT00974233Phase 2Results posted
• Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial MeningiomaTerminatedNCT00972335Phase 2Results posted
• Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00970684Phase 2Results posted
• Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT00966693Phase 1/2Results posted
• Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)CompletedNCT00964795Phase 3Results posted
• Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular MalformationCompletedNCT00964496Phase 2Results posted
• Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00963105Phase 2Results posted
• Sunitinib and Capecitabine for First Line Colon CancerTerminatedNCT00961571Phase 2Results posted
• Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLCTerminatedNCT00960297Phase 2Results posted
• Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)TerminatedNCT00953615Phase 2Results posted
• Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)CompletedNCT00953121Phase 2Results posted
• Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)CompletedNCT00945139Phase 2Results posted
• A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed GlioblastomaCompletedNCT00943826Phase 3Results posted
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT00943072Phase 3Results posted
• A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate CancerCompletedNCT00942578Phase 2Results posted
• Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerCompletedNCT00942331Phase 3Results posted
• Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant GliomasCompletedNCT00939991Phase 1/2Results posted
• Lenalidomide and GM-CSF in Treating Patients With Prostate CancerCompletedNCT00939510Phase 1/2Results posted
• A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian CancerCompletedNCT00937560Phase 2Results posted
• A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell CarcinomaTerminatedNCT00934440Phase 1/2Results posted
• Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung CancerTerminatedNCT00932152Phase 2Results posted
• A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple MyelomaCompletedNCT00928486Phase 3Results posted
• ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic CancerCompletedNCT00925769Phase 1Results posted
• Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast CancerTerminatedNCT00925652Phase 2Results posted
• A Pilot Study of Bevacizumab for Neoplastic MeningitisCompletedNCT00924820Phase 1/2Results posted
• A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung CancerTerminatedNCT00924209Phase 2Results posted
• Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s SarcomaCompletedNCT00923936Phase 2Results posted
• Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney CancerCompletedNCT00923130Phase 2Results posted
• Sunitinib to Treat Recurrent Brain CancerTerminatedNCT00923117Phase 2Results posted
• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and AdenocarcinomaCompletedNCT00917384Phase 3Results posted
• Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) PatientsTerminatedNCT00913913Phase 2Results posted
• Sunitinib Malate in Refractory Germ Cell TumorsTerminatedNCT00912912Phase 2Results posted
• Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00911820Phase 2Results posted
• Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)CompletedNCT00910910Phase 3Results posted
• A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic SyndromesCompletedNCT00910858Phase 1/2Results posted
• Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain MetastasesTerminatedNCT00910039Phase 2Results posted
• Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VDCompletedNCT00908232Phase 2Results posted
• Exemestane With Sunitinib (SUTENT®) in Metastatic Breast CancerTerminatedNCT00905021Phase 1/2Results posted
• BIBF 1120 Versus Bevacizumab in Metastatic Colorectal CancerCompletedNCT00904839Phase 2Results posted
• Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTerminatedNCT00903630Phase 1/2Results posted
• Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell CarcinomaCompletedNCT00903175Phase 2Results posted
• Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular EdemaCompletedNCT00901186Phase 2Results posted
• Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)TerminatedNCT00899431Phase 2Results posted
• Lucentis in Advanced Macular DegenerationCompletedNCT00896779Phase 2Results posted
• Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00895180Phase 2Results posted
• Trial of Poor Performance Status Patients (ToPPS)CompletedNCT00892710Phase 2Results posted
• Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00891878Phase 2Results posted
• A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)CompletedNCT00891735Phase 3Results posted
• Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein StenosisCompletedNCT00891527Phase 1/2Results posted
• Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)CompletedNCT00890929Phase 1/2Results posted
• A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL AmyloidosisCompletedNCT00890552Not applicableResults posted
• A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric CancerCompletedNCT00887822Phase 3Results posted
• Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma SubtypesCompletedNCT00887809Phase 2Results posted
• Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast CancerCompletedNCT00887575Phase 1/2Results posted
• Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT00884741Phase 3Results posted
• Bevacizumab and Lapatinib in Children With Recurrent or Refractory EpendymomaCompletedNCT00883688Phase 2Results posted
• Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver CancerCompletedNCT00881751Phase 2Results posted
• A Study of FOLFOX6 With Bevacizumab for Biliary System CarcinomaTerminatedNCT00881504Phase 2Results posted
• Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer PatientsTerminatedNCT00879619Phase 1/2Results posted
• Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine GliomaCompletedNCT00879437Phase 2Results posted
• Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial CancerCompletedNCT00879359Phase 2Results posted
• Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) TumorsCompletedNCT00876993Phase 1Results posted
• A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)CompletedNCT00875667Phase 2Results posted
• Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal CarcinomaCompletedNCT00868192Phase 2Results posted
• Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00867321Phase 1/2Results posted
• Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage DysplasiaTerminatedNCT00867308Phase 2Results posted
• Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube CancerTerminatedNCT00866723Phase 2Results posted

← Angiogenesis Inhibitors overview